Drugs Made In America Acquisition II Corp. (DMII) stock
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)
Close on Nov 18, 2026Market cap $140.15MP/E –Yield –
Drugs Made In America Acquisition II cash
Cash and short-term investments held at the end of each period.
Drugs Made In America Acquisition II's cash was $118.23K at Sep 30, 2026. For fiscal 2025 it was $223, down 98.7% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $223 | -98.7% |
| FY2024 | Dec 31, 2024 | $17.04K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $118.23K | -62.5% |
| Q2 FY2026 | Jun 30, 2026 | $174.97K | +3882.1% |
| Q1 FY2026 | Mar 31, 2026 | $347.72K | +4873.8% |
| Q4 FY2025 | Dec 31, 2025 | $223 | -98.7% |
| Q3 FY2025 | Sep 30, 2025 | $315.09K | +162.4% |
| Q2 FY2025 | Jun 30, 2025 | $4.39K | – |
| Q1 FY2025 | Mar 31, 2025 | $6.99K | – |
| Q4 FY2024 | Dec 31, 2024 | $17.04K | – |
| Q3 FY2024 | Sep 30, 2024 | $120.07K | – |
See a number that looks wrong?